Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
The Prostate
|
April 6, 2025
PSA Absolute Value Versus PSA Response Rate: Which Is More Valuable for Estimating Survival Outcomes With ARPI Treatment for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in Real-World Analyses?
Tatsuya Shimomura, Naoki Otsuka, Fumihiko Urabe, et al.
International Journal of Clinical Oncology
|
July 15, 2026
Real-world evaluation of primary prophylactic use of granulocyte colony-stimulating factor in patients with metastatic castration-sensitive prostate cancer treated with triplet therapy
Masataka Kubo, Fumihiko Urabe, Kojiro Tashiro, et al.
Japanese Journal of Clinical Oncology
|
January 17, 2025
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative study
Fumihiko Urabe, Soshi Kadena, Kojiro Tashiro, et al.
Clinical Genitourinary Cancer
|
November 25, 2023
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-Analysis
Keiichiro Miyajima, Shun Sato, Naoki Uchida, et al.
Clinical Genitourinary Cancer
|
April 19, 2024
Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study
Chisato Narita, Fumihiko Urabe, Wataru Fukuokaya, et al.
The Prostate
|
April 17, 2026
Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
Tatsuya Shimomura, Masaya Murakami, Kanako Kasai, et al.
Japanese Journal of Clinical Oncology
|
July 23, 2021
Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer
Shunsuke Tsuzuki, Shota Kawano, Wataru Fukuokaya, et al.
Japanese Journal of Clinical Oncology
|
October 19, 2024
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study
Shuhei Hara, Fumihiko Urabe, Kojiro Tashiro, et al.
Translational Andrology and Urology
|
June 10, 2024
Does age impact clinical outcomes of radical nephroureterectomy in the elderly?-results from a multicenter retrospective study
Mimu Ishikawa, Katsuki Muramoto, Kentaro Yoshihara, et al.
Translational Andrology and Urology
|
December 10, 2025
Apalutamide-induced rash and relative dose intensity in metastatic castration-sensitive prostate cancer: a multicenter Japanese cohort study
Fumihiko Urabe, Hajime Onuma, Kojiro Tashiro, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
The Prostate
|
April 6, 2025
PSA Absolute Value Versus PSA Response Rate: Which Is More Valuable for Estimating Survival Outcomes With ARPI Treatment for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in Real-World Analyses?
Tatsuya Shimomura, Naoki Otsuka, Fumihiko Urabe, et al.
International Journal of Clinical Oncology
|
July 15, 2026
Real-world evaluation of primary prophylactic use of granulocyte colony-stimulating factor in patients with metastatic castration-sensitive prostate cancer treated with triplet therapy
Masataka Kubo, Fumihiko Urabe, Kojiro Tashiro, et al.
Japanese Journal of Clinical Oncology
|
January 17, 2025
Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative study
Fumihiko Urabe, Soshi Kadena, Kojiro Tashiro, et al.
Clinical Genitourinary Cancer
|
November 25, 2023
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-Analysis
Keiichiro Miyajima, Shun Sato, Naoki Uchida, et al.
Clinical Genitourinary Cancer
|
April 19, 2024
Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study
Chisato Narita, Fumihiko Urabe, Wataru Fukuokaya, et al.
The Prostate
|
April 17, 2026
Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
Tatsuya Shimomura, Masaya Murakami, Kanako Kasai, et al.
Japanese Journal of Clinical Oncology
|
July 23, 2021
Prognostic model with alkaline phosphatase, lactate dehydrogenase and presence of Gleason pattern 5 for worse overall survival in low-risk metastatic hormone-sensitive prostate cancer
Shunsuke Tsuzuki, Shota Kawano, Wataru Fukuokaya, et al.
Japanese Journal of Clinical Oncology
|
October 19, 2024
Optimal timing for initiating androgen receptor signaling inhibitor therapy in patients with nonmetastatic castration-resistant prostate cancer: a multicenter collaborative study
Shuhei Hara, Fumihiko Urabe, Kojiro Tashiro, et al.
Translational Andrology and Urology
|
June 10, 2024
Does age impact clinical outcomes of radical nephroureterectomy in the elderly?-results from a multicenter retrospective study
Mimu Ishikawa, Katsuki Muramoto, Kentaro Yoshihara, et al.
Translational Andrology and Urology
|
December 10, 2025
Apalutamide-induced rash and relative dose intensity in metastatic castration-sensitive prostate cancer: a multicenter Japanese cohort study
Fumihiko Urabe, Hajime Onuma, Kojiro Tashiro, et al.
Page
of 10